Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

36 results about "Immunization program" patented technology

The goal of the Ohio Department of Health (ODH) Immunization Program is to reduce and eliminate vaccine-preventable diseases among Ohio's children, adolescents and adults. The Immunization Program provides the following services:

Children immunization program information management system

The invention discloses a children immunization program information management system which comprises a children's preventive vaccination certificate, a doctor mobile communication platform and a database. The preventive vaccination certificate is printed with two-dimension codes comprising vaccination children related information; the mobile communication platform is equipped with a preventive vaccination information processing program, wherein the processing program comprises a medicine usage registration module, a vaccination information input module and a vaccination information sending module. The medicine usage registration module is used for recording information of medicine used by a doctor every time; the vaccination information input module is for reading the two-dimension code information on the children's preventive vaccination certificate and for carrying out selection and confirmation on vaccination site, vaccination mode and vaccination medicine information of each vaccination child every time; the vaccination information sending module is for carrying out encryption on the input vaccination information and sending the information to the database, vaccination data being automatically generated when the information is sent; and the database can automatically decode the received vaccination information and can dynamically carry out statistical analysis.
Owner:刘勇军 +1

A method of cultivating quail for eggs using internal and external ecological technology

A method for raising quails for eggs using internal and external ecological technology discloses a method for ecologically raising quails for eggs, which uses natural organic disinfectants instead of daily disinfectants to improve the internal and external environment of quail houses and make the air quality comply with NY/T391 ( Environmental technical conditions for green food production areas) requirements; adding lactic acid bacteria to the quail feed for eggs instead of medicine and health care can regulate the normal flora of the gastrointestinal tract of the egg quail body, maintain the micro-ecological balance, and inhibit the growth and reproduction of spoilage bacteria and the production of spoilage products in the intestinal tract. Effectively reduce harmful gases such as ammonia in quail houses and the odor of feces, improve the breeding environment, and improve the health of laying quails; establish a reasonable immunization program through pathogen investigation and antibody detection to control the occurrence of diseases. After adopting the method, the internal and external environment of the poultry house is greatly improved, the resistance of laying quail to diseases and the prevention of infectious diseases are enhanced, the occurrence of epidemic diseases is controlled, the yield of quail eggs is increased, and the quality of quail eggs is improved.
Owner:河南鹑都实业有限公司

Trivalent inactivated vaccine of porcine reproductive and respiratory syndrome virus, porcine circovirus type 2, and porcine pseudorabies virus and preparation method thereof

The present invention provides a trivalent inactivated vaccine of porcine reproductive and respiratory syndrome virus, porcine circovirus type 2, and porcine pseudorabies virus. Before inactivation, the contents of the three viruses are respectively greater than 10<8.5>TCID[50]/ml 10<6.0>TCID[50] /ml and 10<8.0>TCID[50]/ml; And after the inactivation, the volume ratio of the three antigens is 1:1:1. According to the present invention, via a large number of detailed tests, the contents and ratio of the three viral antigens are selected; and immune effects are measured in a large number of experimental animals and swine themselves, to ensure that the phenomenon of immune interference does not occur among the various immune components in the multivalent vaccine. Compared with the existing three individual vaccines of the same three virus, wherein three injections are need to prevent the three diseases caused by the three virus by using the three individual vaccines, the trivalent inactivated vaccine of the present invention is economical and practical, and simplifies the immunization procedure, and reduces the cost of epidemic prevention. The present invention realizes preparation and application of multivalent inactivated vaccine of porcine reproductive and respiratory syndrome virus, porcine circovirus type 2, and porcine pseudorabies virus, which has not been achieved for all the time in the field.
Owner:PU LIKE BIO ENG

Treatment method of human peripheral blood T lymphocytes, immunogen preparation and application

The invention relates to a treatment method of human peripheral blood T lymphocyte, animmunogen preparation, a preparation method of antiserum, and application. T lymphocytes are separated and purified by using a waste leukocyte filter disc, multiplication culture is carried out, and antigen surface marker identification comparison and activity comparison are carried out on the separated T lymphocytes and the cultured T lymphocytes; the high-activity T lymphocytes subjected to multiplication culture are used as an immunogen, antiserum is prepared by using a healthy pig, the titer after immunization is evaluated by using results of an E rose ring inhibition experiment and a cytotoxicity experiment, and formulating an immunization program, so as to prepare a large amount of antiserum; and anti-plasma is collected for plasma separation, and the plasma separation is used for preparation of ALG products. According to the invention, the limitation problem that fresh whole blood needs to be collected every time in the titer verification of the anti-human T lymphocyte immune globulin preparation raw material and the titer verification of the finished product can be solved, and meanwhile, the bottleneck problem of the anti-human T lymphocyte immune globulin raw material can also be solved.
Owner:武汉中生毓晋生物医药有限责任公司

Composition, Preparation Method And Evaluation Of A Complex Immunogen Named I-SPGA For Production Of Immunological Active Proteins (IAP)

The present invention relates to the composition and method of preparing an immunogen designated as I-spga consisting of a complex antigen prepared from 18 to 26 species of pathogenic microorganisms isolated from patients, inactivated with binary ethyleneamine (BEI) and formalin, diluted in a SPGA immunopotentiator mixed with QS-21 adjuvant. By inoculating the hens with the I-spga immunogen, hyperimmune eggs (Immunospga) are obtained which contain immunologically active proteins specific to the 18-26 antigens used for immunization. The immune response of the hens is specific to the used antigens by amplification of the antigenic signal by the SPGA immunopotentiator and due to a special immunization program that allows the immune system to act complex and intense: The I-spga complex antigen contains 18-26 microorganisms isolated from patients, bacterial bodies, components from bodies obtained by ultrasonography, cilia, exotoxins, endotoxins, spores, viruses, fungi or yeasts. This pathogenic material is inactivated with BEI and formalin. The I-spga antigen is of three types. The standard I-spga antigen is composed of 18 to 24 antibiotic-resistant bacterial species isolated from patients in Romania. The specific I-spga complex antigen is composed of the I-spga complex antigen containing a mixture of 7-9 strains from a single species of bacteria, fungi or yeasts isolated from patients in Romania mixed with SPGA and QS-21, used for inoculation of hens previously immunized with standard I-spga antigen. The personalized I-spga antigen is composed of patient-derived pathological material containing cellular debris and pathogenic germs inactivated with BEI and formalin and mixed with SPGA and QS-21 and is used to immunize hens previously immunized with the standard I-spga antigen. This now patented technology encompasses a new generation of biological products in which the immune response of the hens to different groups of parenterally inoculated antigens at different time intervals is overlapping. Chicken response is uniform and additional administration of immunogens and SPGA as an immunopotentiator amplifies the antigenic signal and immune response. The I-spga immunogen as well as the immune response contain two markers, G and A, which identify the I-spga antigen used for immunization against the antigens used to produce the Imunoinstant group bio-preparations or similar products. The I-spga immunogen is used to immunize the hens for obtaining immunologically active proteins that can be used to treat immune deficiencies, psoriasis, epidermolysis bullosa, other dermatitises, nosocomial infections, antibiotic-resistant infections in the urinary system of children and grownups.
Owner:FANTANA RAUL SORIN +1

A blood analysis system for highly infectious diseases

The present invention provides a blood analysis system for highly infectious diseases in order to solve the technical problems of low biological safety and poor real-time performance of the existing blood analysis system for highly infectious diseases, including a sampling mechanism, a measurement and analysis module, A waste liquid treatment device and a liquid circuit system, the measurement and analysis module is composed of an electrolyte measurement module and a biochemical measurement module, the electrolyte measurement module is connected to the sampling mechanism and connected to the waste liquid treatment device through a peristaltic pump, and the biochemical measurement module is composed of A reagent container, a reagent valve, a peristaltic pump, a sampling valve, a reaction pipeline and a detector are sequentially connected to form, the sampling valve is connected to a sampling mechanism, and the detector is connected to a waste liquid treatment device. Its beneficial effect is that the biological safety is high, all the measurement items are carried out in a closed pipeline, there is no injection during the analysis process, and it has a waste liquid disinfection device; the real-time performance is strong, and the analysis of electrolyte items, biochemical items, and immune items are three Combined into one, the instrument is small in size and can be used in the ward.
Owner:SHENZHEN UNIV +1

Bivalent vaccine for porcine reproductive and respiratory syndrome and classical swine fever prevention or treatment, and preparation method thereof

The present invention provides a bivalent vaccine for porcine reproductive and respiratory syndrome (PRRS) and classical swine fever (CSF) prevention or treatment. The bivalent vaccine comprises the following components: PRRS antigen with a content of at least 10<5>TCID50 / unit, and CSF antigen with a content of at least 7500 rabbit infection dose / unit. The bivalent vaccine preparation method comprises: adopting passage cells to culture PRRS viruses and CSF viruses to obtain PRRS antigens and CSF antigens, mixing the two antigen components according to a certain ratio, and auxiliarily adopting a freeze drying protection agent to prepare the freeze drying vaccine. According to the present invention, the two antigens achieve the appropriate ratio, such that the bivalent vaccine achieves or exceeds efficacy of the original single vaccine; the bivalent vaccine has characteristics of simple preparation method, high titer content and convenient and rapid immunization; compared with fractionated immunization, vaccines for PRRS and CSF prevention and treatment through immunization at least 2 times or 3 times, and immunization methods thereof in the prior art, the bivalent vaccine and the immunization method thereof have characteristics of reduced immunization cost, saved immunization program, economy and reliability.
Owner:PU LIKE BIO ENG

Processing method of human peripheral blood T lymphocytes and immunogen preparation and application

The present invention relates to a treatment method for human peripheral blood T lymphocytes, preparation and application of immunogen preparations and antiserum, in which discarded white blood cell filter discs are used to separate and purify T lymphocytes, and the T lymphocytes are proliferated and cultured, and the isolated T lymphocytes Compared with the cultured T lymphocytes for antigen surface marker identification and activity comparison; then the expanded and cultured highly active T lymphocytes were used as immunogens, and healthy pigs were used to prepare antiserum, and E rosette inhibition experiments and cell Toxicity test results to evaluate the potency after immunization, formulate immunization procedures, and then a large amount of antiserum can be prepared; then anti-plasma is collected for plasma separation and used for the preparation of ALG products. The present invention can solve the restriction problem that fresh whole blood needs to be collected each time in the potency test of raw materials for preparation of anti-human T lymphocyte immunoglobulin and the potency test of finished products, and can also solve the problem of the bottleneck of the raw material of anti-human T lymphocyte immunoglobulin .
Owner:武汉中生毓晋生物医药有限责任公司

Artificial scale domestication method for sika deer for observation and exhibition

ActiveCN112119975AImprove survival rateAdjust the production cycleAnimal husbandryBlood collectionFed cattle
The invention relates to the field of animal domestication, in particular to an artificial scale domestication method for a sika deer for observation and exhibition. The artificial scale domesticationmethod comprises the steps that incubation room temperature and humidity control is carried out; after the one-day-old young deer which is one of two or more fetuses of a female deer and is fed withfirst colostrum is isolated from the female deer, the young deer is fed with bovine colostrum at the age of 1-3 days and is fed with bovine everyday milk at the age of 4-75 days, granular feed and greenish feed are supplemented at the age of 15 days, the young deer is fed with the granular feed and the greenish feed at the age of 76-90 days, and the anus of the young deer is pressed and wiped during feeding; immunizing is carried out according to an immunization program; regular disinfecting is carried out; when the young deer is 3 days old, music is played for the young deer for 1-2 hours ineach of the morning and afternoon every day; the young deer starts to contact crowds at the age of 7 days; the young deer starts to freely move from the age of 15-20 days, wherein the young deer respectively moves for 1-2 h in each of the morning and afternoon every day; after 20 days old, the contact strength is increased until the domestication standard is reached. According to the artificial scale domestication method, the young deer can be domesticated to be in zero-distance contact with a person, such as touch, stroke, feeding and living body non-anesthesia blood collection, and actions such as withering, face fitting, photographing and the like can be performed; and the survival rate of the young deer is 90% or above, and the breeding rate is 80%-90%.
Owner:东丰县梅花鹿产业发展服务中心

A kind of identification method of chicken infectious bronchitis virus

The invention relates to a method for identifying chicken infectious bronchitis virus (IBV). The method is to inoculate SPF chicken embryos into the allantoic cavity of the sample to be tested, and set the SPF chicken embryos inoculated with PBS buffer solution as a control at the same time. Chicken embryos were incubated at 37°C for 24-30 hours, and then inoculated with attenuated Newcastle disease virus strain at 200-2000 times the half infectious dose (EID50) of chicken embryos, and then incubated at 37°C for 48-72 hours to detect the hemagglutination value of chicken embryo allantoic fluid , according to the hemagglutination value judgment result. This method utilizes the characteristic that IBV virus can interfere with the proliferation of chicken Newcastle disease virus (NDV) in chicken embryos, and can be used for laboratory diagnosis, antibody detection and IBV serotype identification of chicken infectious bronchitis, so as to carry out chicken infectious bronchitis vaccine immunization The evaluation of the effect and the monitoring of the epidemic situation provide a theoretical basis for formulating a scientific immunization program and effectively preventing and controlling the occurrence of the disease.
Owner:INST OF ANIMAL SCI & VETERINARY MEDICINE SHANDONG ACADEMY OF AGRI SCI

Composition, preparation method and evaluation of a complex immunogen named I-SPGA for production of immunological active proteins (IAP)

The present invention relates to the composition and method of preparing an immunogen designated as I-spga consisting of a complex antigen prepared from 18 to 26 species of pathogenic microorganisms isolated from patients, inactivated with binary ethyleneamine (BEI) and formalin, diluted in a SPGA immunopotentiator mixed with QS-21 adjuvant. By inoculating the hens with the I-spga immunogen, hyperimmune eggs (Immunospga) are obtained which contain immunologically active proteins specific to the 18-26 antigens used for immunization. The immune response of the hens is specific to the used antigens by amplification of the antigenic signal by the SPGA immunopotentiator and due to a special immunization program that allows the immune system to act complex and intense: The I-spga complex antigen contains 18-26 microorganisms isolated from patients, bacterial bodies, components from bodies obtained by ultrasonography, cilia, exotoxins, endotoxins, spores, viruses, fungi or yeasts. This pathogenic material is inactivated with BEI and formalin. The I-spga antigen is of three types. The standard I-spga antigen is composed of 18 to 24 antibiotic-resistant bacterial species isolated from patients in Romania. The specific I-spga complex antigen is composed of the I-spga complex antigen containing a mixture of 7-9 strains from a single species of bacteria, fungi or yeasts isolated from patients in Romania mixed with SPGA and QS-21, used for inoculation of hens previously immunized with standard I-spga antigen. The personalized I-spga antigen is composed of patient-derived pathological material containing cellular debris and pathogenic germs inactivated with BEI and formalin and mixed with SPGA and QS-21 and is used to immunize hens previously immunized with the standard I-spga antigen. This now patented technology encompasses a new generation of biological products in which the immune response of the hens to different groups of parenterally inoculated antigens at different time intervals is overlapping. Chicken response is uniform and additional administration of immunogens and SPGA as an immunopotentiator amplifies the antigenic signal and immune response. The I-spga immunogen as well as the immune response contain two markers, G and A, which identify the I-spga antigen used for immunization against the antigens used to produce the Imunoinstant group bio-preparations or similar products. The I-spga immunogen is used to immunize the hens for obtaining immunologically active proteins that can be used to treat immune deficiencies, psoriasis, epidermolysis bullosa, other dermatitises, nosocomial infections, antibiotic-resistant infections in the urinary system of children and grownups.
Owner:FANTANA RAUL SORIN +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products